A new method for tolerance induction: Busulfan administration followed by intravenous injection of neuraminidase-treated donor bone marrow

Stem Cells

Volumn 19, Issue 5, 2001, Pages 425-435

  Nagahama, Takashi ^a   Sugiura, Kikuya ^a   Lee, Shinryu ^a   Morita, Haruo ^a   Adachi, Yasushi ^a   Kwon, A Hon ^a   Kamiyama, Yasuo ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone marrow cells; Busulfan; Donor specific tolerance; Intrahepatic retention; Neuraminidase

Indexed keywords

BUSULFAN; CYTOKINE; SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOID ORGAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROCHIMERISM; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PORTAL VEIN; SKIN GRAFT; STEM CELL TRANSPLANTATION; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0034801629     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.19-5-425     Document Type: Article

References (41)

1. Studies on the induction of tolerance to alloantigens. I. The abrogation of potential delayed-type-hypersensitivity responses to alloantigens by portal venous inoculation with allogeneic cells
2. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide
3. Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation
4. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: Immunologically specific entrapment of allogeneic cells within the liver
5. Induction of allogeneic islet survival by intrahepatic islet preimmunization and transient immunosuppression
6. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and supressor factor in the serum
7. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats
8. Immunosuppression induced by hepatic portal venous immunization spares reactivity in IL-4 producing T lymphocytes
9. Impact of perioperative portal venous administration of donor lymphocytes on survival of rat cardiac allografts and renal grafts of the mongrel dog
10. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation for the mechanism of tolerance induction by portal vein injection
11. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells
12. Treatment of intractable autoimmune diseases in MRL/Ipr mice using a new strategy for allogeneic bone marrow transplantation
13. A strategy for organ allografts without using immnosuppressants irradiation
14. Acceptance of skin allograft in pigs by portal venous injection of donor bone marrow cells
15. Abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells
16. Enrichment of natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor associated antigen
17. A surgical technique for experimental free skin grafting in mice
18. Long-term repopulation of hematolymphoid cells with only a few hematopoietic stem cells in mice
19. Immunologic unresponsiveness produced in adult pig by parenteral introduction of minute quantities of hapten or protein antigen
20. Hepatic suppression of sensitization to antigen absorbed into the portal vein
21. The immunology of experimental liver transplantation in the rat
22. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease
23. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat
24. Allogeneic bone marrow transplantation with co-stimulatory blockade induces microchimerism and tolerance without cytoreductive host treatment
25. Bone marrow transplantation as means of inducing tolerance
26. Myeloablation by intravenous busulfan and hematopoietic reconstitution with autologous marrow in a canine model
27. Influence of dimethyl myleran on tolerance induction and immune function in major histocompatibility complex-haploidentical murine bone-marrow transplantation
28. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts
29. Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with buslfan and cyclophosphamide
30. Classical transplantation tolerance in the adult: Interaction between myeloablation and immunosuppression
31. Enhancement of galactose/N-acethyl-glucosamine receptor activity on the surface of freshly isolated rat hepatocytes: Evidence for making of receptor sites by inhibitors derived from collagenase preparations
32. Effect of neuraminidase on the fate of transfused lymphocytes
33. Possible mechanism of entrapment of neuraminidase-treated lymphocytes in liver
34. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor directed interferon
35. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance
36. The liver as a site of T-cell apoptosis: Graveyard, or killing field?
37. Regulation of IFN-gamma and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts
38. Interleukin 12 in combination with anti-interleukin 10 reverse graft prolongation after portal venous immunization
39. A subset of γδ T-cell receptor-positive cells produce T-helper type 2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization
40. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways
41. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice